Literature DB >> 27512044

Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.

Daniel W Carney1, John C Lukesh1, Daniel M Brody1, Manuela M Brütsch1, Dale L Boger2.   

Abstract

Approaches to improving the biological properties of natural products typically strive to modify their structures to identify the essential pharmacophore, or make functional group changes to improve biological target affinity or functional activity, change physical properties, enhance stability, or introduce conformational constraints. Aside from accessible semisynthetic modifications of existing functional groups, rarely does one consider using chemical synthesis to add molecular complexity to the natural product. In part, this may be attributed to the added challenge intrinsic in the synthesis of an even more complex compound. Herein, we report synthetically derived, structurally more complex vinblastines inaccessible from the natural product itself that are a stunning 100-fold more active (IC50 values, 50-75 pM vs. 7 nM; HCT116), and that are now accessible because of advances in the total synthesis of the natural product. The newly discovered ultrapotent vinblastines, which may look highly unusual upon first inspection, bind tubulin with much higher affinity and likely further disrupt the tubulin head-to-tail α/β dimer-dimer interaction by virtue of the strategic placement of an added conformationally well-defined, rigid, and extended C20' urea along the adjacent continuing protein-protein interface. In this case, the added molecular complexity was used to markedly enhance target binding and functional biological activity (100-fold), and likely represents a general approach to improving the properties of other natural products targeting a protein-protein interaction.

Entities:  

Keywords:  chemical synthesis; drug design; protein–protein interaction; tubulin; vinblastine

Mesh:

Substances:

Year:  2016        PMID: 27512044      PMCID: PMC5024590          DOI: 10.1073/pnas.1611405113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 2.  Microtubules as a target for anticancer drugs.

Authors:  Mary Ann Jordan; Leslie Wilson
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

3.  Tubulin aggregation and disaggregation: mediation by two distinct vinblastine-binding sites.

Authors:  B Bhattacharyya; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

4.  Synthesis of a Potent Vinblastine: Rationally Designed Added Benign Complexity.

Authors:  Oliver Allemann; Manuela Brutsch; John C Lukesh; Daniel M Brody; Dale L Boger
Journal:  J Am Chem Soc       Date:  2016-07-01       Impact factor: 15.419

5.  3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.

Authors:  J D Jiang; A S Davis; K Middleton; Y H Ling; R Perez-Soler; J F Holland; J G Bekesi
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

Review 6.  Modifications in the "upper" velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities.

Authors:  J Fahy
Journal:  Curr Pharm Des       Date:  2001-09       Impact factor: 3.116

7.  10'-Fluorovinblastine and 10'-Fluorovincristine: Synthesis of a Key Series of Modified Vinca Alkaloids.

Authors:  Hiroaki Gotoh; Katharine K Duncan; William M Robertson; Dale L Boger
Journal:  ACS Med Chem Lett       Date:  2011-12-08       Impact factor: 4.345

8.  New insights into the mechanism and an expanded scope of the Fe(III)-mediated vinblastine coupling reaction.

Authors:  Hiroaki Gotoh; Justin E Sears; Albert Eschenmoser; Dale L Boger
Journal:  J Am Chem Soc       Date:  2012-08-07       Impact factor: 15.419

9.  Potent Vinblastine C20' Ureas Displaying Additionally Improved Activity Against a Vinblastine-Resistant Cancer Cell Line.

Authors:  Timothy J Barker; Katharine K Duncan; Katerina Otrubova; Dale L Boger
Journal:  ACS Med Chem Lett       Date:  2013-09-09       Impact factor: 4.345

Review 10.  Total synthesis of vinblastine, related natural products, and key analogues and development of inspired methodology suitable for the systematic study of their structure-function properties.

Authors:  Justin E Sears; Dale L Boger
Journal:  Acc Chem Res       Date:  2015-01-14       Impact factor: 22.384

View more
  13 in total

1.  The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry.

Authors:  Zhi-Chen Wu; Dale L Boger
Journal:  Nat Prod Rep       Date:  2020-11-10       Impact factor: 13.423

Review 2.  Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.

Authors:  Deepali Waghray; Qinghai Zhang
Journal:  J Med Chem       Date:  2017-12-28       Impact factor: 7.446

3.  High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs.

Authors:  Aleksandar Radakovic; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2018-02-06       Impact factor: 2.823

4.  Key analogs of a uniquely potent synthetic vinblastine that contain modifications of the C20' ethyl substituent.

Authors:  Oliver Allemann; R Matthew Cross; Manuela M Brütsch; Aleksandar Radakovic; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2017-05-18       Impact factor: 2.823

5.  Ultra-potent vinblastine analogues improve on-target activity of the parent microtubulin-targeting compound.

Authors:  Aleksandar Radakovic; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2019-03-26       Impact factor: 2.823

Review 6.  Inverse Electron Demand Diels-Alder Reactions of Heterocyclic Azadienes, 1-Aza-1,3-Butadienes, Cyclopropenone Ketals, and Related Systems. A Retrospective.

Authors:  Jiajun Zhang; Vyom Shukla; Dale L Boger
Journal:  J Org Chem       Date:  2019-05-23       Impact factor: 4.354

7.  Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.

Authors:  John C Lukesh; Daniel W Carney; Huijun Dong; R Matthew Cross; Vyom Shukla; Katharine K Duncan; Shouliang Yang; Daniel M Brody; Manuela M Brütsch; Aleksandar Radakovic; Dale L Boger
Journal:  J Med Chem       Date:  2017-08-31       Impact factor: 7.446

8.  Total synthesis of (-)-4-desacetoxy-1-oxovindoline: Single atom exchange of an embedded core heteroatom in vindoline.

Authors:  Byron A Boon; Yi-Yun Yu; Dale L Boger
Journal:  Tetrahedron       Date:  2021-03-29       Impact factor: 2.457

Review 9.  Synthesis of Bisindole Alkaloids from the Apocynaceae Which Contain a Macroline or Sarpagine Unit: A Review.

Authors:  Md Toufiqur Rahman; Veera V N Phani Babu Tiruveedhula; James M Cook
Journal:  Molecules       Date:  2016-11-14       Impact factor: 4.411

Review 10.  Bisindole Alkaloids from the Alstonia Species: Recent Isolation, Bioactivity, Biosynthesis, and Synthesis.

Authors:  Kamal P Pandey; Md Toufiqur Rahman; James M Cook
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.